MENU
APR 24, 2020 8:00 AM PDT

The International Council for Standardisation in Hematology (ICSH) recommendations for Hemostasis Critical Values, Tests, and Reporting - a stepwise description for the committee's decisions

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Clinical Laboratory Scientist
    Biography
      I am a licensed Clinical Laboratory Scientist in the state of California having retired from the University of California, Davis Health System (UCDHS) in 2017 after 30 years of service, with the last 23 years as the Sr Specialist in Special Coagulation section of the Pathology and Laboratory Medicine department. I currently serve as a staff volunteer with the Hemostasis & Thrombosis Center at UCDHS and the Thrombosis Subcommittee for UCDHS, a working group of the institution's Pharmacy and Therapeutics committee. I serve on the board and several committees for the International Council for Standardisation in Hematology (ICSH) and a former board member for the North American Specialized Coagulation Laboratory Association (NASCOLA) and the International Society for Laboratory Hematology (ISLH). I also serve as an associate editor for the Journal of Thrombosis and Haemostasis, former associate editor for the International Journal for Laboratory Hematology (IJLH), and currently serve as editorial board member for Seminars in Thrombosis and Hemostasis and the IJLH. I have authored or co-authored 99 articles, and 5 book chapters, with the most recent manuscripts focusing on laboratory testing of direct oral anticoagulants and laboratory quality issues.

    Abstract

    The International Council for Standardization in Haematology (ICSH) is a nonprofit organization dedicated to providing open-access guidance documents to enhance the quality of laboratory testing and practice.  A recently published ICSH initiative centered on providing laboratory guidance to 1) identify all coagulation tests with potential patient risk based on test methodology, test result, and patient presentations, 2) recommend critical result thresholds; 3) provide acceptable reporting and documenting mechanisms, and 4) delineate the required elements for  laboratory policies.  Theis presentation will describe the rationale for critical values/tests recommendations by renowned opinion leaders in the field of laboratory coagulation.

    At the conclusion of this webinar attendees will be able to:
    1) understand and define the difference between a critical value and a critical test,
    2) describe the recommended coagulation tests with associated with critical values,
    3) identify the recommended elements for reporting and documenting critical values, and
    4) apply the recommended requirements for a critical value/test laboratory policy

     

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.  CE credits are available for this webinar up to 2 years from the date of the live broadcast


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources
    Attendees
    • See more